Irbesartan
Product Images NDC 71335-0423

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 71335-0423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 And 2 (Irbesartan Fig1 2)

Two scatter plots with fitted curves depicting the placebo-subtracted reduction in trough systolic blood pressure (SeSBP) and diastolic blood pressure (SeDBP) as related to Irbesartan dose (mg/day). The left graph shows reduction in SeSBP (mmHg) while the right graph shows reduction in SeDBP (mmHg) with increasing Irbesartan dose up to 900 mg/day.*

FDA Label Image

Figure 3 (Irbesartan Fig3)

A cumulative event rate line graph showing Irbesartan, Amlodipine, and Placebo groups over a 60-month follow-up period. The graph compares event rates (%) with months of follow-up on the x-axis and cumulative event rate on the y-axis. Included is a risk ratio (RR) and p-value table comparing Irbesartan to Placebo and Amlodipine.*

FDA Label Image

Structure (Irbesartan Str)

Chemical structure of irbesartan, showing its molecular skeleton with multiple rings and functional groups consistent with its active ingredient identification.*

FDA Label Image

Label Image (Lbl713350423)

Packaging label for Irbesartan 150 mg Tablet, labeled by Bryant Ranch Prepack in Burbank, CA. The label compares the product to Avapro 150 mg Tablet by Alembic Pharmaceuticals Inc. It includes storage instructions, a lot number, an NDC number 71335-0423-1, and a barcode. The tablet is described as a white oval.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.